A new weapon is emerging in the war against pancreatic cancer

U.S. and Japanese researchers have come up with a novel, image-based way to track stem cell signals so as to halt pancreatic cancer in its tracks.

Because reporter activity of the stem-cell gene Msi can be visualized by live imaging, “these models can be used to track cancer stem cells within the tumor microenviroment,” explained Tannishtha Reya, PhD, of UC-San Diego School of Medicine.

This may provide “a real-time view of cancer growth and metastasis,” she added, and serve “as a platform to test new drugs that may be better able to eradicate resistant cells.”

The newsroom at UC-San Diego Health has the story: 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.